1 Min Read
March 6 (Reuters) - Cumberland Pharmaceuticals Inc:
* CUMBERLAND PHARMACEUTICALS REPORTS 25% REVENUE GROWTH FOR THE FULL YEAR 2017
* Q4 REVENUE ROSE 28 PERCENT TO $11.6 MILLION Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.